4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001780854-25-000002
Chief Commercial Ofc Imm Med sold 606,402 shares at an average $16.73 ($10,144,026)
- Chief Commercial Ofc Imm Med acquired 510,470 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
BENZENO SHARON · Chief Commercial Ofc Imm Med
Table I: Non-derivative
10 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-11-20 | Exercise or conversion : show line 1 in the form 10b5-1 | +133,032 | $8.46 | $1,125,451 | 525,755 | D |
| 2025-11-20 | Exercise or conversion : show line 2 in the form 10b5-1 | +68,961 | $12.14 | $837,187 | 594,716 | D |
| 2025-11-20 | Sale : show line 3 in the form 10b5-1 | −297,925 | $16.54 | $4,927,680 | 296,791 | D |
| 2025-11-21 | Exercise or conversion : show line 4 in the form 10b5-1 | +834 | $6.27 | $5,229 | 297,625 | D |
| 2025-11-21 | Exercise or conversion : show line 5 in the form 10b5-1 | +20,834 | $6.55 | $136,463 | 318,459 | D |
| 2025-11-21 | Exercise or conversion : show line 6 in the form 10b5-1 | +49,480 | $6.55 | $324,094 | 367,939 | D |
| 2025-11-21 | Exercise or conversion : show line 7 in the form 10b5-1 | +34,375 | $7.27 | $249,906 | 402,314 | D |
| 2025-11-21 | Exercise or conversion : show line 8 in the form 10b5-1 | +119,809 | $12.14 | $1,454,481 | 522,123 | D |
| 2025-11-21 | Exercise or conversion : show line 9 in the form 10b5-1 | +83,145 | $3.99 | $331,749 | 605,268 | D |
| 2025-11-21 | Sale : show line 10 in the form 10b5-1 | −308,477 | $16.91 | $5,216,346 | 296,791 | D |
| Open-market sales · 606,402 sh · avg $16.73 · $10,144,026 | ||||||
Table II: Derivative
8 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-11-20 | Exercise or conversion : show line 11 in the form 10b5-1 Stock Option (right to buy) | −133,032 | 66,517 | D |
| 2025-11-20 | Exercise or conversion : show line 12 in the form 10b5-1 Stock Option (right to buy) | −68,961 | 136,970 | D |
| 2025-11-21 | Exercise or conversion : show line 13 in the form 10b5-1 Stock Option (right to buy) | −834 | 0 | D |
| 2025-11-21 | Exercise or conversion : show line 14 in the form 10b5-1 Stock Option (right to buy) | −20,834 | 0 | D |
| 2025-11-21 | Exercise or conversion : show line 15 in the form 10b5-1 Stock Option (right to buy) | −49,480 | 0 | D |
| 2025-11-21 | Exercise or conversion : show line 16 in the form 10b5-1 Stock Option (right to buy) | −34,375 | 0 | D |
| 2025-11-21 | Exercise or conversion : show line 17 in the form 10b5-1 Stock Option (right to buy) | −119,809 | 17,161 | D |
| 2025-11-21 | Exercise or conversion : show line 18 in the form 10b5-1 Stock Option (right to buy) | −83,145 | 116,404 | D |
Loading xslF345X05/primary_doc.xml…